Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flamel Technologies SA (NASDAQ:FLML)

During the Trading Day
23.30 -0.62 / -2.59%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
24.01 +0.71 / +3.03%
 
Volume: 5.4K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$962.9M

Company Description

Flamel Technologies SA is a specialty pharmaceutical company with drug delivery and formulation expertise. It engages in the development, manufacture, and marketing of pharmaceutical products. The company operates under the following trademarks: Bloxiverz, DeliVax, Flamel Technologies, LiquiTime, Micropump, Medusa, Trigger Lock and Vazculep. Flamel Technologies was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.

Contact Information

Flamel Technologies SA
33, avenue du Dr. Georges Lévy
Vénissieux Rhone-alpes 69200
P:(347) 278-3434
Investor Relations:

Employees

Shareholders

Other institutional48.22%
Mutual fund holders27.80%
Individual stakeholders--

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Rafael JordaChief Operating Officer & Executive Vice President
Siân CrouzetChief Financial Officer
Christian KalitaChief Pharmacist, Director-Quality & Regulatory
David MonteithVice President-Research & Development